
About 1.4% of U.S. adults (over 3 million people) experience Borderline Personality Disorder (BPD) in a typical year. But BPD...
Read More

Depression that doesn’t respond to conventional treatments is a serious problem for all who are affected, and poses unique risks...
Read More

On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach...
Read More

Researchers have published results of experiments in rodents suggesting that lithium, a widely prescribed mood stabilizer, may have value as...
Read More

In its first randomized, placebo-controlled test, an enhanced form of non-invasive brain stimulation called SNT (Stanford Neuromodulation Therapy, formerly called...
Read More